Objective: To better define the serology of a panel of sera from patients with a clinical diagnosis of systemic lupus erythematosus (SLE) or subacute cutaneous lupus erythematosus (SCLE) with a negative antinuclear antibody (ANA) test on mouse liver.
Methods: Sensitive ELISA methods for anti-Ro/SSA, anti-La/SSB, and anti-U1RNP were applied to a panel of 76 sera with either SLE or SCLE and a negative ANA test on mouse liver.
Results: These sera had previously been shown to have a high prevalence of anti-Ro/SSA (68%) and anti-La/SSB (27%) precipitins respectively. None had precipitins to U1RNP or Sm. ELISA methodology revealed that all of the sera 76=76 (100%) had elevated levels (Mean±2SDofa panel of 21 normal sera) of anti-Ro/SSA, 36=76 (46%) had elevated levels of anti-La/SSB, and 27 of 76 (35%) had elevated levels of anti-U1RNP.
Conclusion: The subset of patients with SLE and SCLE with a negative ANA test on mouse liver almost uniformly have antibodies to the Ro/SSA antigen by a sensitive ELISA. This adds evidence to the idea that this is a more homogeneous disease subset within the spectrum of SLE.
Maddison PJ , Provost TT , Reichlin M . Serological findings in patients with ‘ANA-Negative’ Systemic Lupus Erythematosus . Medicine1981; 60: 87–94 .
2.
Gilliam JN . The cutaneous signs of lupus erythematosus . Continuing Education for the Family Physician1977; 6: 34–40 .
3.
Sontheimer RD , Thomas JR , Gilliam JN . Subacute cutaneous lupus erythematosus <Eth> A cutaneous marker for a distinct lupus erythematosus subset . Arch Dermatol1979; 115: 1409–1415 .
4.
Sontheimer RD , Maddison PJ , Reichlin M et al. Serological and HCA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus . Ann Intern Med1982; 96: 664–671 .
5.
Reichlin M , Harley JB . Detection by ELISA of antibodies to small RNA protein particles in systemic lupus erythematosus patients whose sera lack precipitins . Trans Assoc Am Physicians1986; 49: 161–171 .
6.
Harley JB , Yamagata H , Reichlin M . Anti-La/SSB antibody is present in some normal sera and is coincident with anti-Ro/SSA precipitins in systemic lupus erythematosus . J Rheumatol1984; 11: 309%–314 .
7.
Gordon T , Mavrangelos C , McCluskey J . Restricted epitope recognition by precipitin-negative anti-La/SS-B positive sera . Arthritis Rheum1992; 35: 663–666 .
8.
Reichlin M . Disease specific autoantibodies in the systemic rheumatic diseases. In: Rose NR , Mackay IR (eds.). The Autoimmune Diseases II. Academic Press: San Diego , 1992, pp. 195–209.
9.
Bartholomew BA . Antinuclear antibody tests as a clinically selected screening procedure . Am J Clin Pathol1974; 61: 495–499 .
10.
Estes D , Christian CL . The natural history of systemic lupus erythematosus by prospective analysis . Medicine1971; 50: 85–94 .
11.
Fessel WJ . ANA negative systemic lupus erythematosus . Am J Med1977; 64: 80–86 .
12.
Gladman DD , Chalmers A , Urowitz MB . Systemic lupus erythematosus with negative LE cell and antinuclear factor . J Rheumatol1978; 5: 142–147 .
13.
Pollak VE . Antinuclear antibodies in families of patients with systemic lupus erythematosus . New Engl J Med1964; 271: 165–171 .
14.
Provost TT , Ahmed AR , Maddison PJ , Reichlin M . Antibodies to cytoplasmic antigens in lupus erythematosus. Serological marker for systemic disease . Arthritis Rheum1977; 20: 1457–1463 .
15.
Reichlin M , Wolfson-Reichlin M . Autoantibodies to the Ro/SS-A particle react preferentially with the human antigen . J Autoimmun1989; 2: 359–365 .
16.
Reichlin M , Rader M , Harley JB . Autoimmune response to the Ro/SSA particle is directed to the human antigen . Clin Exp Immunol1989; 76: 373–377 .
17.
Wasicek CA , Maddison PJ , Reichlin M . Occurrence of antibodies to single stranded DNA in ANA negative patients . Clin Exp Immunol1979; 37: 190–195 .
